Engineered-Rice Theft by Chinese Companies to Be Probed at ITC

Jan. 17, 2021, 9:57 PM UTC

The U.S. International Trade Commission has begunan investigation into allegations that a Chinese company is importing genetically-engineered rice seeds for medical uses that copy patented technology owned by Kansas developer Ventria Bioscience.

  • Ventria said it developed rice seeds to produce a protein called albumin used in the manufacture of medicines like immunotherapy drugs, gene therapies and vaccines, including ones for Covid-19
  • Wuhan Healthgen, a company founded by a former Ventria scientist, is making a plant-based albumin using techniques patented by Ventria, according to the complaint
    • Ventria said it had filed a civil trade secret suit against the former ...



Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.